Abstract
Purpose
The rise of fatal stimulant use among adults who use opioids is a public health problem. Internalized stigma is a barrier to substance use treatment, which is greater for women and populations with criminal justice involvement.
Methods
Using a nationally representative sample of adults in the United States from a probability-based survey on household opinions in 2021, we examined characteristics of women (n = 289) and men (n = 416) who misuse opioids. In gender-stratified multivariable linear regression, we investigated factors associated with internalized stigma, and tested for the interaction of stimulant use and criminal justice involvement.
Results
Compared to men, women reported greater mental health symptom severity (3.2 vs. 2.7 on a 1 to 6 scale, p < 0.001). Internalized stigma was similar between women (2.3 ± 1.1) and men (2.2 ± 0.1). Among women and not men, however, stimulant use was positively associated with internalized stigma (0.36, 95% CI [0.07, 0.65]; p = 0.02). Interaction between stimulant use and criminal justice involvement was negatively associated with internalized stigma among women (− 0.60, 95% CI [− 1.16, -0.04]; p = 0.04); among men, the interaction was not significant. Predictive margins illustrate among women, stimulant use eliminated the gap in internalized stigma such that women with no criminal justice involvement had a similar level of internalized stigma as women with criminal justice involvement.
Conclusion
Internalized stigma between women and men who misuse opioids differed based on stimulant use and criminal justice involvement. Future research should assess whether internalized stigma influences treatment utilization among women with criminal justice involvement.
Similar content being viewed by others
References
Ahmad FB, Cisewski JA, Rossen LM, Sutton P (2022) Provisional drug overdose death counts: national center for health statistics. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed 1 Dec 2022
Glick SN, Klein KS, Tinsley J, Golden MR (2021) Increasing heroin-methamphetamine (goofball) use and related morbidity among seattle area people who inject drugs. Am J Addict 30(2):183–191
Goodwin RD, Moeller SJ, Zhu J, Yarden J, Ganzhorn S, Williams JM (2021) The potential role of cocaine and heroin co-use in the opioid epidemic in the United States. Addict Behav 113:106680
Ellis MS, Kasper ZA, Cicero TJ (2018) Twin epidemics: the surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend 193:14–20
Arendt V, Guillorit L, Origer A, Sauvageot N, Vaillant M, Fischer A et al (2019) Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. PLoS One 14(5):e0215570
Chawarski MC, Hawk K, Edelman EJ, O’Connor P, Owens P, Martel S et al (2020) Use of amphetamine-type stimulants among emergency department patients with untreated opioid use disorder. Ann Emerg Med 76(6):782–787
National Academies of Sciences E, and Medicine Medication for opioid use disorder saves lives 2019
Ronsley C, Nolan S, Knight R, Hayashi K, Klimas J, Walley A et al (2020) Treatment of stimulant use disorder: a systematic review of reviews. PLoS One 15(6):e0234809
Tsui JI, Mayfield J, Speaker EC, Yakup S, Ries R, Funai H et al (2020) Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. J Subst Abuse Treat 109:80–85
Salehi M, Emadossadat A, Kheirabadi GR, Maracy MR, Sharbafchi MR (2015) The effect of buprenorphine on methamphetamine cravings. J Clin Psychopharmacol 35(6):724–727
Ciccarone D (2021) The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry 34(4):344–350
Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD (2009) Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 105(1–2):83–88
Matusow H, Dickman SL, Rich JD, Fong C, Dumont DM, Hardin C et al (2013) Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat 44(5):473–480
Scott CK, Dennis ML, Grella CE, Mischel AF, Carnevale J (2021) The impact of the opioid crisis on US state prison systems. Health Justice 9(1):17
Livingston JD, Boyd JE (2010) Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med 71(12):2150–2161
Hatzenbuehler ML, Phelan JC, Link BG (2013) Stigma as a fundamental cause of population health inequalities. Am J Public Health 103(5):813–821
Brener L, Caruana T, Broady T, Cama E, Ezard N, Madden A et al (2022) Addressing injecting related risks among people who inject both opioids and stimulants: findings from an Australian survey of people who inject drugs. Addict Behav Rep 15:100398
Kulesza M, Watkins KE, Ober AJ, Osilla KC, Ewing B (2017) Internalized stigma as an independent risk factor for substance use problems among primary care patients: rationale and preliminary support. Drug Alcohol Depend 180:52–55
Birtel MD, Wood L, Kempa NJ (2017) Stigma and social support in substance abuse: implications for mental health and well-being. Psychiatry Res 252:1–8
LeBel TP (2012) If one doesn’t get you another one will: formerly incarcerated persons’ perceptions of discrimination. Prison J 92(1):63–87
Howell BA, Earnshaw VA, Garcia M, Taylor A, Martin K, Fox AD (2022) The stigma of criminal legal involvement and health: a conceptual framework. J Urban Health 99(1):92–101
Major B, O’Brien LT (2005) The social psychology of stigma. Annu Rev Psychol 56:393–421
Crocker J, Major B (1989) Social stigma and self-esteem: the self-protective properties of stigma. Psychol Rev 96:608–630
Meyers SA, Earnshaw VA, D’Ambrosio B, Courchesne N, Werb D, Smith LR (2021) The intersection of gender and drug use-related stigma: a mixed methods systematic review and synthesis of the literature. Drug Alcohol Depend 223:108706
Edelman NL, Patel H, Glasper A, Bogen-Johnston L (2014) Sexual health risks and health-seeking behaviours among substance-misusing women. J Adv Nurs 70(12):2861–2870
Syvertsen JL, Toneff H, Howard H, Spadola C, Madden D, Clapp J (2021) Conceptualizing stigma in contexts of pregnancy and opioid misuse: a qualitative study with women and healthcare providers in Ohio. Drug Alcohol Depend 222:108677
Fazel S, Yoon IA, Hayes AJ (2017) Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction 112(10):1725–1739
Sawyer W, Wagner P (2023) Mass incarceration: the whole pie 2023. Prison policy initiative. https://www.prisonpolicy.org/reports/pie2023.html. Accessed 8 June 2023
Statistics BoJ (1986) Historical Corrections Statistics in the United States 1850–1984. In: Justice USDo, editor
Statistics BoJ (2021) Prison and Jail Inmates at Midyear Series (1997–2020), Prisoners Series (1980–2020). In: Justice USDo, editor. Washington, DC
Taylor BG, Lamuda PA, Flanagan E, Watts E, Pollack H, Schneider J (2021) Social stigma toward persons with opioid use disorder: results from a nationally representative survey of US adults. Subst Use Misuse 56(12):1752–1764
Dennis JM (2019) AmeriSpeak Omnibus Field Report.
Bilgen I, Dennis JM, Ganesh N (2018) Nonresponse Follow-up Impact on AmeriSpeak Panel Sample Composition and Representativeness. In: NORC, editor. Chicago, IL
Montgomery R, Dennis JM, Ganesh N (2018) Response rate calculation methodology for recruitment of a two-phase probability-based panel: The Case of AmeriSpeak. In: Chicago NatUo, editor
Luoma JB, Nobles RH, Drake CE, Hayes SC, O’Hair A, Fletcher L et al (2013) Self-stigma in substance abuse: development of a new measure. J Psychopathol Behav Assess 35(2):223–234
Veit CT, Ware JE Jr (1983) The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 51(5):730–742
Berwick DM, Murphy JM, Goldman PA, Ware JE Jr, Barsky AJ, Weinstein MC (1991) Performance of a five-item mental health screening test. Med Care 29(2):169–176
Ware J, Snow K, Kosinski M, Gandek B (1993) SF36 Health Survey: Manual and Interpretation Guide. In: The Health Institute NEMC, editor
StataCorp (2019) Stata statistical software: release 16. StataCorp LLC, College Station
Grella CE, Lovinger K (2012) Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addict Behav 37(3):306–312
Grella CE (2008) From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs (Suppl 5):327–343
Greenfield SF, Grella CE (2009) What is “women-focused” treatment for substance use disorders? Psychiatr Serv 60(7):880–882
Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG (2010) Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates. Am J Public Health 100(3):476–482
Bello JK, Hearing C, Salas J, Weinstock J, Linhorst D (2020) Trends in substance use by gender among participants in a jail-based substance use disorder treatment program: 1998–2016. J Forensic Sci 65(1):97–102
Herrman H, Stewart DE, Diaz-Granados N, Berger EL, Jackson B, Yuen T (2011) What is resilience? Can J Psychiatry 56(5):258–265
Li X, Qiao S, Yang X, Harrison SE, Tam CC, Shen Z et al (2022) A Resilience-based intervention to mitigate the effect of HIV-related stigma: protocol for a stepped wedge cluster randomized trial. Front Public Health 10:857635
Sedić B, Štrkalj Ivezić S, Petrak O, Ilić B (2021) Differences in resilience, self-stigma and mental health recovery between patients with schizophrenia and depression. Psychiatr Danub 33(Suppl 4):518–528
Webster LR (2017) Risk factors for opioid-use disorder and overdose. Anesth Analg 125(5):1741–1748
Novak P, Feder KA, Ali MM, Chen J (2019) Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: evidence from a national survey. J Subst Abuse Treat 98:47–52
Mauritz MW, Goossens PJ, Draijer N, van Achterberg T (2013) Prevalence of interpersonal trauma exposure and trauma-related disorders in severe mental illness. Eur J Psychotraumatol. https://doi.org/10.3402/ejpt.v4i0.19985
McKay MT, Cannon M, Chambers D, Conroy RM, Coughlan H, Dodd P et al (2021) Childhood trauma and adult mental disorder: a systematic review and meta-analysis of longitudinal cohort studies. Acta Psychiatr Scand 143(3):189–205
Rosic T, Au VYO, Worster A, Marsh DC, Thabane L, Samaan Z (2021) Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study. BJPsych Open 7(4):e138
Van Denend J, Harris JI, Fuehrlein B, Edens EL (2022) Moral injury in the context of substance use disorders: a narrative review. Curr Treat Options Psychiatry 9(4):321–330
Lewer D, Freer J, King E, Larney S, Degenhardt L, Tweed EJ et al (2020) Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis. Addiction 115(6):1011–1023
Cohen A, Vakharia SP, Netherland J, Frederique K (2022) How the war on drugs impacts social determinants of health beyond the criminal legal system. Ann Med 54(1):2024–2038
Binswanger IA, Blatchford PJ, Mueller SR, Stern MF (2013) Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med 159(9):592–600
Tourangeau R, Yan T (2007) Sensitive questions in surveys. Psychol Bull 133(5):859–883
Khalili P, Nadimi AE, Baradaran HR, Janani L, Rahimi-Movaghar A, Rajabi Z et al (2021) Validity of self-reported substance use: research setting versus primary health care setting. Subst Abuse Treat Prev Policy 16(1):66
National Academies of Sciences E (2022) Medicine. In: Bates N, Chin M, Becker T (eds) Measuring sex, gender identity, and sexual orientation. The National Academies Press, Washington, p 200
Paschen-Wolff MM, Kidd JD, Paine EA (2023) The state of the research on opioid outcomes among lesbian, gay, bisexual, transgender, queer, and other sexuality- and gender-diverse populations: a scoping review. LGBT Health 10(1):1–17
Funding
This work was supported by Grant 1U2CDA050098-01 via a subcontract, AWD100228, with the University of Chicago and by Grant 1UG1DA050067-01 (MassJCOIN). Funding came from the National Institute of Health’s (NIH) National Institute on Drug Abuse (NIDA), Justice Community Opioid Innovation Network (JCOIN), protocol approval number JCOIN 027. The funder had no role in the study design, collection, analysis, or interpretation of data, manuscript preparation, or manuscript submission.
Author information
Authors and Affiliations
Contributions
AB, BG, and EE contributed to study conceptualization and methodology. BG and EE provided supervision. AB conducted data analysis and data visualization. AB and BG drafted the manuscript. AB, BG, HP, JS, and EE provided comments and finalized and approved the submitted version.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bailey, A., Taylor, B.G., Pollack, H.A. et al. Gender identity, stimulant drug use, and criminal justice history on internalized stigma among a nationally representative sample of adults who misuse opioids. Soc Psychiatry Psychiatr Epidemiol 59, 305–313 (2024). https://doi.org/10.1007/s00127-023-02500-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-023-02500-5